Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Francois Baclesse
Age
1–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Age \>18
Female
Histologically proven diagnosis of localised, non-metastatic breast cancer
Indication for neo-adjuvant or adjuvant anthracycline and taxane chemotherapy (3 or 4 EC100 followed by 3 Docetaxel or 3 or 4 EC100 plus 9 to 12 Paclitaxel); HER-positive status is not a non-inclusion criterion.
Patient willing to be photographed to assess IFA
Fluency in French
Patient affiliated to a social security scheme
Signature of informed consent
You may not be if
History of neck pain
Pre-existing alopecia
Participation in another trial
Dermatosis of the scalp
Contraindication to scalp cooling
History of migraines, stroke or hyperthyroidism
History of scalp metastases
Sensitivity to cold, cold agglutinin disease, cryoglobulinaemia, cryofibrinogenaemia or post-traumatic cold dystrophy.
Malignant haemopathies
History of chemotherapy treatment
Indication for cerebral irradiation
Pregnant or breast-feeding patient
Raynaud's syndrome
Clareo Health | Prevention of Alopecia in Patients With Localised Breast Cancer
